90
Participants
Start Date
October 31, 2023
Primary Completion Date
April 30, 2027
Study Completion Date
April 30, 2027
Letermovir 240 mg Oral Tablet
Treatment will commence as soon as subjects can receive oral medication, with a maximum timeframe of 28 days after transplantation. If patients cannot receive oral medication after transplantation, initial prophylaxis with ganciclovir per clinical practice will be allowed. Medication will be discontinued 12 months after treatment initiation.
Hospital Universitario Reina Sofia, Córdoba
MERCK SHARP & DOHME DE ESPAÑA S.A.
UNKNOWN
Maimónides Biomedical Research Institute of Córdoba
OTHER